A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 1 August 2022) has been published and includes articles on: Nebulised asthma rescue therapy in children: home use of nebulisers in paediatric asthma should be initiated and managed only by specialists COVID-19 vaccines and medicines: updates for August 2022 Letters [...]
The post MHRA Drug Safety Update August 2022 appeared first on PSNC Website.
The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocols (SSPs) for Fluoxetine 10mg tablets (SSP005) and Lipitor® 10mg chewable tablets (SSP032). SSP005 for Fluoxetine 10mg tablets was due to expire on 12 August 2022 but the end date has been further extended to Wednesday 7 December 2022. [...]
The post Contractor notice: Extension to SSPs for Fluoxetine 10mg tablets (SSP005) and Atorvastatin 10mg chewable tablets (SSP032) appeared first on PSNC Website.
Following applications made by PSNC to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), a further 28 new products entered the list of ‘Drugs for which Discount is Not Deducted’ (DND) in Part II of the Drug Tariff from 1 August 2022: For a list of all the monthly [...]
The post 28 products added to the Discount Not Deducted (DND) list from August 2022 appeared first on PSNC Website.
Recent Comments